HIV-positive New Yorkers are living longer but still dying from underlying infection, not just from old age

August 28, 2019

A review of the autopsy reports of 252 men and women who died of acquired immunodeficiency syndrome (AIDS) in New York City between 1984 and 2016 reveals several long-term trends in combatting the epidemic. The infectious disease is known for drastically lowering the body's immune defenses and is spread by the human immunodeficiency virus, or HIV.

The researchers at NYU School of Medicine and NYU Long Island School of Medicine who led the study say their analysis is the largest review of autopsy-verified causes of death since a similar California report in 2000, and almost 40 years since the epidemic was recognized by health officials in 1981.

"Our study accurately reflects the history of the epidemic in New York City, which still has the highest number of new HIV infections per year in the United States," says senior study investigator Amy Rapkiewicz, MD.

"Autopsy reports reliably tell the whole disease story and why people are still dying from it," says Rapkiewicz, an associate professor in the Department of Pathology at NYU Langone Health and vice chair of pathology at NYU Winthrop Hospital on Long Island. "That is because there is often a difference between the immediately reported cause of death, such as a heart attack, and the actual cause of death, whether from obesity, drug use, or HIV/AIDS."

Among the key findings in the report, publishing in the Archives of Pathology and Laboratory Medicine online Aug. 28, is that early in the HIV epidemic in 1984, the average age of death in the city from AIDS was 36. By 2010, the average age had risen to 54.

Rapkiewicz credits this increase in lifespan to the development of combination antiviral drug therapies in the 1990s that prevent HIV from reproducing and infecting other cells, but, she says, "people are still dying predominantly from the underlying disease and not just factors related to old age."

According to researchers, infections such as pneumocystis pneumonia in the lungs are still the leading cause of death (accounting for 100 percent of deaths between 1984 and 1987, 52 percent between 1996 and 1999, and 86 percent from 2012 to 2016). "Even a treated HIV-positive patient is immunocompromised and at increased risk of dying from pneumonia," says Rapkiewicz.

And now that people are living longer with HIV, she says, other common co-infections, such as viral hepatitis C, which takes years to damage the liver, are starting to emerge as causes and contributors of death. Three-quarters of those autopsied between 2014 and 2016 had hepatitis C and cirrhosis, a severe and potentially deadly scarring of the liver.

However, researchers expect that recent advances in drug therapies for hepatitis C will drive down these numbers in the near future.

One study finding that remains to be explained by future autopsy reports, they say, is the sharp increase in hardened and fat-narrowed arteries from atherosclerosis among those dying with HIV. Between 1988 and 1991, atherosclerosis was found in 21 percent of those autopsied, but for the years 2008 to 2011, the condition was found in 54 percent.

Lead study investigator Sobia Nizami, MD, a clinical fellow in infectious diseases at NYU Langone, says it is difficult to assess if this trend is due to HIV-positive people simply living longer, overeating, and adopting the sedentary lifestyles widely seen among non-infected Americans, or if something more worrisome, such as long-term side effects of antiviral medications, are at the root of the problem. Body fat deposits seen with earlier anti-HIV drugs were, she says, mostly eliminated with later versions of the drugs.

The investigators say their study was designed in part to educate more clinicians, not just physicians, but also physician assistants and nurse practitioners, about the importance of accurately documenting death certificates to properly reflect people's HIV status and the main cause of death. The researchers caution that their analysis only reflects the disease's trends in New York City, not nationally.
For the study, self-funded by NYU Langone, researchers reviewed all the autopsy records at NYC Health + Hospitals/Bellevue of people who died with HIV. The hospitals' HIV clinic is the city's largest and serves a predominantly poor community with higher than average rates of drug use, a risk factor for HIV infection.

Experts estimate that more than 100,000 New Yorkers have died of AIDS-related causes since the epidemic began, and 125,000 are currently living with HIV. In 2017, the city recorded more than 2,100 new cases of HIV infection.

NYU Langone study co-investigators included Robert Holzman, MD, who has treated people living with HIV in New York since the beginning of the epidemic. Additional research support was provided by students Kelly Hu and Cameron Morales.

Media Inquiries:

David March

NYU Langone Health / NYU School of Medicine

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to